Mediwound announces u.s. commercial availability of nexobrid® for the treatment of severe thermal burns in adults

Full commercial launch of nexobrid marks important first step to becoming the new standard of care for eschar removal in patients with deep partial- and/or full- thickness thermal burns full commercial launch of nexobrid marks important first step to becoming the new standard of care for eschar removal in patients with deep partial- and/or full- thickness thermal burns
MDWD Ratings Summary
MDWD Quant Ranking